Poster ARVO 2014 :

Posted on

RAVE  2 Study : Two years treatment follow up with intravitreal ranibizumab (Lucentis®) and verteporfin PDTRF  combination therapy at month 2 for neovascular age-related macular degeneration (AMD)
M. Dominguez – E. Fourmaux – L. Rosier – L. Velasque    Centre Rétine Gallien  Bordeaux – France
Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3961. doi:
 

Autres actualités